Be Ahead With Economy And Policy Updates
New Delhi: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr.
Mumbai: Global pharma major Lupin Limited (Lupin) announced the launch of Atharv Ability, its world-class neuro-rehabilitation center in Naraina Vihar, Delhi, dedicated to
Mumbai: JB Chemicals & Pharmaceuticals Ltd (“The Company”) announced its financial results for the fourth quarter of FY 26 on Monday. India Business:
Chennai: Caplin Steriles Limited (CSL), a Subsidiary Company of Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), has been granted final approval
Bangalore: OneSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE), a leading specialty pharmaceutical CDMO, today announced that its partner Orbicular, along with its
MUMBAI: Sun Pharma Advanced Research Company Ltd. (SPARC) (Reuters: SPRC.BO, Bloomberg: SPADV IN, NSE: SPARC, BSE: 532872) today announced that SPARC has entered
New Delhi: India’s pharmacy industry is achieving new heights in the US market. India’s leading pharmaceutical company Sun Pharma has proposed 11.75‑billion‑dollar acquisition
Gurugram: Jagsonpal Pharmaceuticals Limited (BSE: 507789, NSE: JAGSNPHARM) today announced the audited financial results for the quarter and year ended March 31, 2026.
New Delhi: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for
Ahmedabad: Zydus Lifesciences Limited (“Zydus”), an innovation-led global lifesciences company, announced that it has received permission to conduct two Phase III clinical trials
Newsletter
Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Binimetinib Tablets, 45 mg
BCPL Railway Infra Bags Rs. 46.18 Million Work Under Sealdah Division of Eastern Railway
Intense Technologies Announces Retirement of Founder C.K. Shastri
ACS Technologies Achieves CMMI Maturity Level 3 Appraisal For DEV and SVC Domains
